Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice

Nature Nanotechnology

Volumn 4, Issue 7, 2009, Pages 451-456

  Mitchell, L A ^a,b   Lauer, F T ^b   Burchiel, S W ^b   McDonald, J D ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY; ENZYMES; MAMMALS; NANOTUBES; YARN;

CYCLOOXYGENASES; EXPOSED TO; IMMUNE FUNCTION; IMMUNE SUPPRESSION; KNOCKOUT MICE; POTENTIAL HEALTH; SPLEEN CELLS; WHOLE BODY;

MULTIWALLED CARBON NANOTUBES (MWCN);

CYCLODEXTRIN; CYCLOOXYGENASE 2; IBUPROFEN; MULTI WALLED NANOTUBE; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; EXPOSURE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KNOCKOUT MOUSE; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MOLECULAR MECHANICS; MOUSE; NANOTOXICOLOGY; NONHUMAN; PHAGOCYTOSIS; PRESSURE CHAMBER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN CELL; SPLEEN FUNCTION;

EID: 67651227154     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2009.151     Document Type: Article

References (22)

1. Stern, S. T. & McNeil, S. E. Nanotechnology safety concerns revisited. Toxicol. Sci. 101, 4-21 (2008).
2. Lam, C. W., James, J. T., McCluskey, R. & Hunter, R. L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126-134 (2004).
3. Muller, J. et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 207, 221-231 (2005).
4. Shvedova, A. A. et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L698-L708 (2005).
5. Warheit, D. B. et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77, 117-125 (2004).
6. Mitchell, L. A. et al. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol. Sci. 100, 203-214 (2007).
7. Li, J. G. et al. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ. Toxicol. 22, 415-421 (2007).
8. Deng, X. et al. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 45, 1419-1424 (2007).
9. Bide, R. W., Armour, S. J. & Yee, E. Allometric respiration/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans. J. Appl. Toxicol. 20, 273-290 (2000).
10. Miller, F. J. Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: a critical review. Inhal. Toxicol. 12, 19-57 (2000).
11. Godwin, D. A., Wiley, C. J. & Felton, L. A. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen. Eur. J. Pharm. Biopharm. 62, 85-93 (2006).
12. Cheng, Y. S., Marshall, T. C., Henderson, R. F. & Newton, G. J. Use of a jet mill for dispersing dry powder for inhalation studies. Am. Ind. Hyg. Assoc. J. 46, 449-454 (1985).
13. Maynard, A. D., Baron, P. A., Foley, M., Shvedova, A. A., Kisin, E. R. & Castranova, V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. Toxicol. Environ. Health A 67, 87-107 (2004).
14. Beck-Speier, I. et al. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. Environ. Health Perspect. 109 (Suppl. 4), 613-618 (2001).
15. Burchiel, S. W. PGI2 and PGD2 effects on cyclic AMP and human T-cell mitogenesis. Prostaglandins Med. 3, 315-320 (1979).
16. Chemnitz, J. M. et al. Prostaglandin E2 impairs CD4+ T-cell activation by inhibition of lck: implications in Hodgkin's lymphoma. Cancer Res. 66, 1114-1122 (2006).
17. Choudhry, M. A. et al. Role of NFAT and AP-1 in PGE2-mediated T-cell suppression in burn injury. Shock 18, 212-216 (2002).
18. Freire-de-Lima, C. G. et al. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J. Biol. Chem. 281, 38376-38384 (2006).
19. Kim, W. J., Kim, J. H. & Jang, S. K. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of elF4A. EMBO J. 26, 5020-5032 (2007).
20. Porter, D. W. et al. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages. J. Tox. Environ. Health 70, 1967-1976 (2007).
21. Fionda, C., Nappi, F., Piccoli, M., Frati, L., Santoni, A. & Cippetelli, M. PGJ2 negatively regulated rankl gene expression in activated T lymphocytes: Role of NFkB and early growth response transcription factors. J. Immunol. 178, 4039-4050 (2007).
22. Rajakariar, R. et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy 12, 14, PGJ2. Proc. Natl Acad. Sci. USA 104, 20979-20984 (2007).